CD8A and neoplasm: The cholesterol esterification enzyme acetyl-CoA acetyltransferase (ACAT1) knockout in CD8+ T cells was found to downregulate membrane cholesterol and improve T cell receptor clustering and signaling, enhancing CD8+ T cell function and anti-tumor immunity in mouse tumor models [56].